Response efficacy of PD-1 and PD-L1 inhibitors in clinical trials: a systematic review and meta-analysis
S Chen, Z Zhang, X Zheng, H Tao, S Zhang… - Frontiers in …, 2021 - frontiersin.org
Background Immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway have demonstrated
promise in treating a variety of advanced cancers; however, little is known regarding …
promise in treating a variety of advanced cancers; however, little is known regarding …
Investigation of formaldehyde and TVOC in underground malls in Xi'an, China: Concentrations, sources, and affecting factors
H Tao, Y Fan, X Li, Z Zhang, W Hou - Building and Environment, 2015 - Elsevier
Along with the speeding up of Chinese urbanization process, the contradiction between
urban land demand and supply had increased significantly, more and more underground …
urban land demand and supply had increased significantly, more and more underground …
The synergistic effect of PARP inhibitors and immune checkpoint inhibitors
Z Wu, P Cui, H Tao, S Zhang, J Ma… - Clinical Medicine …, 2021 - journals.sagepub.com
Poly (ADP-ribose) polymerase (PARP) inhibitors have demonstrated great promise for
treating cancers with homologous recombination (HR) defects, such as germline BRCA1/2 …
treating cancers with homologous recombination (HR) defects, such as germline BRCA1/2 …
[HTML][HTML] Rate and risk factors of recurrent immune checkpoint inhibitor-related pneumonitis in patients with lung cancer
H Tao, F Li, D Wu, S Ji, Q Liu, L Wang… - Translational Lung …, 2022 - ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICIs) have become standard treatments for lung
cancer patients. Immune checkpoint inhibitor-related pneumonitis (CIP) was the leading …
cancer patients. Immune checkpoint inhibitor-related pneumonitis (CIP) was the leading …
[HTML][HTML] Systemic immune-inflammation index and changes of neutrophil-lymphocyte ratio as prognostic biomarkers for patients with pancreatic cancer treated with …
J Shang, X Han, H Zha, H Tao, X Li, F Yuan… - Frontiers in …, 2021 - frontiersin.org
The efficacy of current treatment regimens for pancreatic cancer (PC) remains unsatisfactory.
In recent years, immune checkpoint blockade (ICB) therapy has shown promising anti-…
In recent years, immune checkpoint blockade (ICB) therapy has shown promising anti-…
A loop-mediated isothermal amplification method targets the phoP gene for the detection of Salmonella in food samples
X Li, S Zhang, H Zhang, L Zhang, H Tao, J Yu… - International journal of …, 2009 - Elsevier
A loop-mediated isothermal amplification (LAMP) assay was developed and validated for
the specific detection of Salmonella in food. The assay used specifically designed primers to …
the specific detection of Salmonella in food. The assay used specifically designed primers to …
Comparative effectiveness of pembrolizumab vs. nivolumab in patients with recurrent or advanced NSCLC
P Cui, R Li, Z Huang, Z Wu, H Tao, S Zhang, Y Hu - Scientific Reports, 2020 - nature.com
The efficacies of pembrolizumab and nivolumab have never been directly compared in a
real-world study. Therefore, we sought to retrospectively evaluate the objective response rate (…
real-world study. Therefore, we sought to retrospectively evaluate the objective response rate (…
[HTML][HTML] Acquired multiple secondary BRCA2 mutations upon PARPi resistance in a metastatic pancreatic cancer patient harboring a BRCA2 germline mutation
H Tao, S Liu, D Huang, X Han, X Wu… - American journal of …, 2020 - ncbi.nlm.nih.gov
PARP inhibitor (PARPi) therapies have been approved for treating multiple germline BRCA
mutated (gBRCAm) advanced cancers including metastatic pancreatic cancer. Although …
mutated (gBRCAm) advanced cancers including metastatic pancreatic cancer. Although …
Pretreatment hemoglobin level as a predictor to evaluate the efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
…, Q Ou, Z Liu, B Yang, L Wang, H Tao… - Therapeutic …, 2020 - journals.sagepub.com
Background: Targeting immune checkpoints represents an immense breakthrough in cancer
therapeutics. The prognostic value of hemoglobin (Hb) has been investigated in many …
therapeutics. The prognostic value of hemoglobin (Hb) has been investigated in many …
[HTML][HTML] Demethylation of miR-9-3 and miR-193a genes suppresses proliferation and promotes apoptosis in non-small cell lung cancer cell lines
J Wang, B Yang, L Han, X Li, H Tao, S Zhang… - Cellular Physiology and …, 2013 - karger.com
Background: MicroRNAs miR-9-3 and miR-193a have recently been found to be hypermethylated
in a variety of non-small cell lung cancer (NSCLC) cells and primary human tumors. …
in a variety of non-small cell lung cancer (NSCLC) cells and primary human tumors. …
